undamentalytics Newsletter
Sign in

Acadia Pharmaceuticals Inc balance sheet

At the end of fiscal 2025, Acadia Pharmaceuticals Inc had total assets of $1.56bn, total liabilities of $337m and shareholders' equity of $1.23bn. It held $178m in cash against $0 of debt: net cash of $178m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents187758126210216469135190326147115189320178385
Receivables———————61726364864629899121151
Inventory———————45461014124092111109
Total current assets—38321091883252195483735267607186185086169381,0621,225
Total assets—38321091893252225613855407837837005887491,1881,5641,743
Accounts payable—2210224937871318161145
Deferred revenue (current)—1100——3——————————
Total current liabilities—666716224349607510696126254395277361
Short-term debt—00———————————————
Total debt000000000000000000
Total liabilities—9967162243496184156159187317455337436
Shareholders' equity123023851823092005183354796996275414004327331,2271,307
Non-controlling interests and other (assets − liabilities − equity)———18——————————————
Net debt (negative = net cash)−18−7−7−58−12−62−102−164−69−135−190−326−147−115−189−320−178−385
Shares outstanding—39m53m—91m100m102m121m124m144m155m160m161m162m165m167m170m172m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ACAD vs PTCTACAD vs LKFTACAD vs LEGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Acadia Pharmaceuticals Inc's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Acadia Pharmaceuticals Inc.